VEGFA and diabetes mellitus: Recent clinical study revealed that increased circulating VEGF-A in type 2 diabetic patients was correlated with glycemic control, high-sensitive C-reactive protein, and albuminuria, suggesting the role of VEGF-A as a biomarker of inflammation and nephropathy in diabetes [32].